Please provide your email address to receive an email when new articles are posted on . Harrow announced it will begin marketing and selling Vigamox, a fluoroquinolone antibiotic eye drop for ...
NASHVILLE, Tenn.--(BUSINESS WIRE)--Harrow (NASDAQ: HROW), a leading U.S. eyecare pharmaceutical company, today announced the completion of the transfer to Harrow of the New Drug Application (NDA) for ...
The Food and Drug Administration recently announced recalls of several eye drop brands linked to an outbreak of drug-resistant bacteria responsible for four deaths and multiple cases of people going ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback